What type of study is this?

October 23, 2025Respiratory ResearchOpen Access

Efficacy and safety of remimazolam-based sedation for intensive care unit patients undergoing fiberoptic bronchoscopy: a single-center prospective randomized controlled study

View Full Paper

Ask AI

Bookmark

Authors

Randomized controlled study shows remimazolam has similar sedation efficacy and improved safety in ICU patients with liver dysfunction.

Remimazolam demonstrated lower incidence of hypotension compared to propofol during sedation.
Patients in the remimazolam group required fewer sedation rescues, suggesting enhanced safety.
Prospective randomized controlled study indicates both sedatives achieved similar sedation depth in patients.
Findings highlight the potential for remimazolam as a safer alternative in critically ill patients undergoing bronchoscopy.

He et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark